SYNBIO.INTEL
DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Tune Therapeutics
activeFounded 2021

Tune Therapeutics

HQ: Durham, NC, USACEO: Fyodor Urnov (co-founder)Headcount: 80+tunetx.com ↗
Funding Summary
Total Funding
$275M+
Latest Valuation
Undisclosed
About

Develops precision epigenome editing therapies using the TEMPO platform to tune gene expression up or down without altering DNA sequence.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →